Maharat Nakhon Ratchasima Hospital is the main hospital of Nakhon Ratchasima Province, Thailand and is classified under the Ministry of Public Health as a regional hospital. It is the largest regional hospital in Thailand under the responsibility of the ministry and has 1,387 beds.

There are 1,387 beds in Maharat Nakhon Ratchasima Hospital.

During the past decade, Maharat Nakhon Ratchasima Hospital conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Maharat Nakhon Ratchasima Hospital" #1 sponsor was "Arcus Biosciences, Inc." with 1 trials, followed by "Dental Innovation Foundation Under Royal Patronage" with 1 trials sponsored, "Institut de Recherche pour le Developpement" with 1 trials sponsored, "Ipsen" with 1 trials sponsored and "Novartis" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Maharat Nakhon Ratchasima Hospital" #1 collaborator was "Bhumibol Adulyadej Hospital" with 1 trials as a collaborator, "Buddhachinnaraj Hospital" with 1 trials as a collaborator, "Chiang Rai Prachanukroh Hospital" with 1 trials as a collaborator, "Fondation de France" with 1 trials as a collaborator and "Gilead Sciences" with 1 trials as a collaborator. Other collaborators include 11 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "Maharat Nakhon Ratchasima Hospital" are "Cervical Cancer" (1 trials), "Chronic Constipation" (1 trials), "HIV-infected Participants With Latent TB Infection in High TB Burden Country" (1 trials), "Head and Neck Neoplasms" (1 trials) and "Lung Cancer" (1 trials). Many other conditions were trialed in "Maharat Nakhon Ratchasima Hospital" in a lesser frequency.

Most popular intervention types in "Maharat Nakhon Ratchasima Hospital" are "Drug" (4 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (1 trials), "Domvanalimab" (1 trials), "Isoniazid/Rifapentine 12-weekly plus pyridoxine (vitamin B6)" (1 trials), "Isoniazid/Rifapentine daily (4 weeks) plus pyridoxine (vitamin B6)" (1 trials) and "Lactulose active and Lactulose placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Maharat Nakhon Ratchasima Hospital" are 5 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Maharat Nakhon Ratchasima Hospital". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Maharat Nakhon Ratchasima Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Maharat Nakhon Ratchasima Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".